Moderna’s Covid-19 Vaccine Works Safely in Adolescents, Company Says

  • 📰 WSJ
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Moderna plans to ask regulators next month to approve its Covid-19 vaccine for 12- to 17-year-olds after a study showed it was effective in adolescents

More than 5 million adolescents aged 12 to 17 years have received at least one dose of a Covid-19 vaccine so far, according to the Centers for Disease Control and Prevention Director Rochelle Walensky.Expanded use of Moderna’s shot could bolster plans to hold summer camps for children and ease the return of full-time, in-person instruction in middle and high schools in the fall.

Moderna and Pfizer have also begun testing their vaccines in younger children. Results are expected later in the year.Pfizer has started to test its Covid-19 vaccine in children ages six months to 11 years old. In this video, some of the first recipients -- twin sisters from North Carolina -- receive their vaccinations. Photo: Shawn Rocco/Duke Health

About four weeks after the second dose, researchers took blood samples from study subjects and measured the levels of neutralizing antibodies, which are components of the immune system that can block the coronavirus from replicating.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Why? This age group has been deemed low risk. Not worth it. Do no harm.

mRNA VACCINE and Heart Inflammation in Younger patients

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 98. in İD

Indonesia Berita Terbaru, Indonesia Berita utama